X4 Pharmaceuticals Company
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Headquarters:
Cambridge, Massachusetts, United States
Industry:
Biotechnology, Clinical Trials, Health Care, Pharmaceutical, Therapeutics
Employee Number:
51-100
Estimated Revenue:
Less than $1M
Investors Number:
12
Investor Type:
IPO
Funding Status:
IPO
Technology:
Data-driven Technologies
Last Funding Type:
Post-IPO Equity
Founded Date:
2014
Total Funding:
119499999
Last Funding Date:
2021